
Atomo Diagnostics is a leader in medical device design and development, specialized in innovative rapid diagnostic test (RDT) device platforms for capillary blood testing. Atomo's all-in-one devices put the end user first, and help to prevent user errors that are common with standard, multi-component RDT kits. The recipient of multiple international awards for design innovation, Atomo's device platforms make it easy to test and screen for a range of infectious diseases and chronic conditions. As well as commercializing products in its own brand, Atomo provides OEM product development services to specialist diagnostic companies worldwide.
Primary contact Bloxham, United Kingdom
Funding 💰
Total $13.1M
Select investors Global Health Investment Fund, Sydney Angels, Bill & Melinda Gates Foundation
Last update: May 10, 2018